GENEVA, June 16 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/062321) for "BIPHENYL AND PHENYLPYRIDINE COMPOUNDS AS INHIBITORS OF KAT2A AND/OR KAT2B" on Dec 06, 2024. With publication no. WO/2025/120592, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DONALDSON, Joyann Susan (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), GALLEGO, Rebecca Anne (c/o Pfizer Inc.10777 Science Center DriveSan Diego, California 92121), HOFFMAN, Jacqui Eliza...